34 lines
No EOL
1.6 KiB
JSON
34 lines
No EOL
1.6 KiB
JSON
{
|
|
"rejected_claims": [
|
|
{
|
|
"filename": "dietary-guidelines-have-no-funding-mechanism-creating-institutional-versus-individual-impact-split.md",
|
|
"issues": [
|
|
"missing_attribution_extractor"
|
|
]
|
|
},
|
|
{
|
|
"filename": "maha-food-first-rhetoric-serves-dual-agenda-of-food-quality-improvement-and-pharmaceutical-cost-resistance.md",
|
|
"issues": [
|
|
"missing_attribution_extractor"
|
|
]
|
|
}
|
|
],
|
|
"validation_stats": {
|
|
"total": 2,
|
|
"kept": 0,
|
|
"fixed": 4,
|
|
"rejected": 2,
|
|
"fixes_applied": [
|
|
"dietary-guidelines-have-no-funding-mechanism-creating-institutional-versus-individual-impact-split.md:set_created:2026-03-18",
|
|
"dietary-guidelines-have-no-funding-mechanism-creating-institutional-versus-individual-impact-split.md:stripped_wiki_link:SDOH-interventions-show-strong-ROI-but-adoption-stalls-becau",
|
|
"maha-food-first-rhetoric-serves-dual-agenda-of-food-quality-improvement-and-pharmaceutical-cost-resistance.md:set_created:2026-03-18",
|
|
"maha-food-first-rhetoric-serves-dual-agenda-of-food-quality-improvement-and-pharmaceutical-cost-resistance.md:stripped_wiki_link:GLP-1-receptor-agonists-are-the-largest-therapeutic-category"
|
|
],
|
|
"rejections": [
|
|
"dietary-guidelines-have-no-funding-mechanism-creating-institutional-versus-individual-impact-split.md:missing_attribution_extractor",
|
|
"maha-food-first-rhetoric-serves-dual-agenda-of-food-quality-improvement-and-pharmaceutical-cost-resistance.md:missing_attribution_extractor"
|
|
]
|
|
},
|
|
"model": "anthropic/claude-sonnet-4.5",
|
|
"date": "2026-03-18"
|
|
} |